Article
Heparanase wildtype is associated with a reduced incidence of transplant-associated systemic vasculopathies.
Hematology/oncology and stem cell therapy - 4 Apr 2023
Mueckenhausen Raphaela, Föll Jürgen, Kleinschmidt Katharina, Tröger Anja, Malaisé Muriel, Wolff Daniel, Holler Ernst, Matthes Marie, Heise Tilman, Sommer Gunhild, Corbacioglu Selim
Abstract excerpt
Some of the early complications of hematopoietic stem cell transplantation (HSCT) concerning the small vessels can be summarized as transplant-associated systemic vasculopathies (TASV). One enzyme known to play a major role in inflammation, tissue remodeling, and repair processes as well as tumor metastasis is heparanase (HPSE). HPSE genetic variants have recently been associated with significant influence on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
